title: Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
authors.forename: T
authors.initials: T
authors.lastname: Arai
authors.forename: Y
authors.initials: Y
authors.lastname: Yasuda
authors.forename: T
authors.initials: T
authors.lastname: Takaya
authors.forename: S
authors.initials: S
authors.lastname: Toshima
authors.forename: Y
authors.initials: Y
authors.lastname: Kashiki
authors.forename: N
authors.initials: N
authors.lastname: Yoshimii
authors.forename: H
authors.initials: H
authors.lastname: Fujiwara
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D011015:Pneumonia, Aspiration / Q000517:prevention & control; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D013373:Substance P / Q000097:blood
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007093:Imidazoles; D048289:Imidazolidines; D013373:Substance P; C065166:imidapril; D019808:Losartan